In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones
July 25th, 2019
10.7K views
Ubiquitination is a post-translational modification that plays important roles in cellular processes and is tightly coordinated by deubiquitination. Defects in both reactions underlie human pathologies. We provide protocols for conducting ubiquitination and deubiquitination reaction in vitro using purified components.
Overview
This article discusses the importance of ubiquitination and deubiquitination in cellular processes and their implications in human diseases. It provides protocols for conducting these reactions in vitro using purified components.
Key Study Components
Area of Science
- Cellular processes
- Post-translational modifications
- Human pathologies
Background
- Ubiquitination and deubiquitination are crucial for regulating various cellular functions.
- Defects in these processes can lead to diseases.
- In vitro assays help elucidate the mechanisms involved.
- Understanding mutations in related enzymes can provide insights into disease mechanisms.
Purpose of Study
- To establish in vitro assays for ubiquitination and deubiquitination.
- To identify domains and motifs that drive these reactions.
- To develop high throughput screening assays for potential therapeutics.
Methods Used
- Preparation of lysis buffer with PMSF and antiprotease cocktail.
- Resuspension of bacterial pellets in lysis buffer.
- Sonication of lysate to extract components.
- Use of purified components for in vitro reactions.
Main Results
- Successful establishment of in vitro ubiquitination and deubiquitination assays.
- Identification of key domains and motifs in the enzymes.
- Development of assays for screening small molecule inhibitors.
- Insights into the relationship between enzyme mutations and disease.
Conclusions
- In vitro assays are essential for understanding ubiquitination mechanisms.
- Identifying enzyme domains can aid in therapeutic development.
- Further research is needed to explore the implications of these findings in human diseases.
Frequently Asked Questions
What is ubiquitination?
Ubiquitination is a post-translational modification that tags proteins for degradation or alters their function.
Why are in vitro assays important?
In vitro assays allow researchers to study complex cellular processes in a controlled environment using purified components.
How can mutations in enzymes affect human health?
Mutations in enzymes involved in ubiquitination can disrupt cellular processes and lead to various diseases.
What are small molecule inhibitors?
Small molecule inhibitors are compounds that can block the activity of specific enzymes, potentially serving as therapeutic agents.
What role does deubiquitination play?
Deubiquitination removes ubiquitin tags from proteins, reversing the effects of ubiquitination and regulating protein function.
What is the significance of identifying enzyme domains?
Identifying enzyme domains helps understand their function and can guide the development of targeted therapies.
Executive Industry Relevance
Establishing robust in vitro ubiquitination and deubiquitination assays with purified components enables mechanistic interrogation of E3 ligase and DUB activity, supporting target validation and assay development in early drug discovery. These assays provide quantitative, reproducible readouts that facilitate screening for modulators of chromatin-regulating enzymes, informing lead identification and preclinical de-risking strategies. By defining the biochemical requirements for nucleosomal histone modification, the method supports translational continuity from target engagement to functional pathway analysis.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables direct interrogation of E3 ubiquitin ligase (e.g., BMI1-RING1B) and deubiquitinase (e.g., BAP1-DEUBAD) activity on physiologically relevant nucleosomal substrates.
- Operational Value: Uses defined, purified components to isolate variables and establish causal relationships between enzyme function and histone H2AK119 ubiquitination status.
- Predictive Value: Supports mechanistic de-risking by linking enzymatic activity to chromatin function, aiding in target confidence assessment for epigenetic modulators.
Screening & Assay Development
- Scientific Value: Provides a homogeneous, quantitative platform to measure ubiquitin transfer and removal kinetics, enabling detection of small molecule modulators.
- Operational Value: Compatible with high-throughput formats due to reliance on purified enzymes, defined nucleosomes, and standardized buffer conditions (e.g., buffer H/I, Laemmli sample buffer for detection).
- Reproducibility Value: Minimizes confounding cellular variables, allowing consistent readouts across experiments and laboratories for assay standardization.
Translational & Preclinical Research
- Translational Value: Uses native nucleosomes purified from mammalian cells (e.g., HEK293T) to maintain physiological relevance, bridging recombinant systems to disease-relevant chromatin context.
- Mechanistic Insight: Enables assessment of how disease-associated mutations in ubiquitin pathway enzymes alter enzymatic activity on nucleosomal substrates.
- Preclinical Alignment: Supports evaluation of target engagement and functional modulation in a chromatin environment reflective of native epigenetic regulation.
Pipeline & Workflow Integration
The assay fits within the early discovery continuum, supporting target validation through mechanistic de-risking and enabling lead identification via screening-competent formats for ubiquitin pathway modulators.
- Discovery Biology: Supports hypothesis testing of E3 ligase and DUB function by isolating enzymatic activity on defined nucleosomal substrates, clarifying mechanism of action.
- Screening: Enables assay readiness through standardized reaction conditions (e.g., 37°C incubation, defined enzyme:nucleosome ratios) and immunoblot-based detection of ubiquitination shifts.
- Analytics: Generates quantitative, time-dependent readouts (e.g., loss/gain of H2AK119ub signal) that allow comparison of enzyme activity under varying conditions (e.g., inhibitor presence, mutant enzymes).
- Translational Research: Uses native nucleosomes to maintain epigenetic context, supporting continuity from in vitro mechanism to cellular phenotype.
- Enterprise Reuse: Protocol principles (purified components, defined buffers, nucleosome preparation) are adaptable to other E3/DUB pairs, enabling platform reuse across epigenetic target classes.
Operational & Enterprise Impact
- Scientific Value: Provides mechanistic clarity on ubiquitin pathway enzymes, reducing ambiguity in target function and supporting predictive confidence in epigenetic targeting.
- Operational Value: Standardized purification and reaction protocols enhance reproducibility and scalability across discovery teams.
- Strategic Value: Enables earlier go/no-go decisions by linking target modulation to functional chromatin outcomes, reducing late-stage biological risk.
- Portfolio Impact: Supports risk-adjusted prioritization of epigenetic targets based on validated enzymatic activity and modulator responsiveness.
Implementation Considerations
- Expertise in protein purification (e.g., GST, His-tag, MBP affinity), nucleosome reconstitution, and immunoblot detection is required.
- Instrumentation includes sonicator, centrifuge, chromatography columns, and imaging systems for western blot analysis.
- Standardization across teams requires consistent use of defined buffers (e.g., lysis buffers A-F, buffer H/I) and nucleosome preparation methods (recombinant or native).
- Adaptation to other E3/DUB pairs requires validation of enzyme compatibility with nucleosomal substrates and buffer conditions.
- Phenol-chloroform and reducing agents used in nucleosome isolation require handling in fume hoods due to hazardous properties.
Biopharma FAQs
Why does isolating E3 ligase activity on nucleosomes matter for target validation?
Isolating E3 ligase activity on nucleosomal histones allows direct measurement of ubiquitin transfer efficiency, enabling mechanistic de-risking by confirming target engagement and functional output in a defined system.
How does using purified components support assay development for ubiquitin pathway screening?
Using purified enzymes and defined nucleosomes eliminates cellular variability, enabling reproducible, quantitative readouts essential for high-throughput screening of small molecule inhibitors or activators.
What quantitative measurements enable assessment of deubiquitination efficiency in vitro?
Immunoblot-based detection of histone H2AK119ub signal loss over time provides a quantitative readout of deubiquitination activity, allowing comparison of DUB function under varying conditions.
Why are replication requirements important for cross-functional collaboration in ubiquitin assay workflows?
Replication ensures consistent ubiquitination/deubiquitination outcomes across laboratories and teams, supporting reliable data transfer between discovery, screening, and preclinical groups.
What statistical analysis capabilities are required before implementing ubiquitination assays in drug discovery?
The ability to quantify signal changes (e.g., ubiquitinated vs. non-modified histone bands) and compare across conditions (e.g., time, inhibitor concentration) is required to assess enzyme activity and modulator effects.
Chapters in this video
0:04
Title
1:01
GSH-agarose Affinity Purification of the GST-RING1B(1-159)-BMI1 (1-109) E3 Ubiquitin Ligase Complex
2:16
Purification of the BAP1/DEUBAD (ASXL2) Deubiquitinase Complex
4:58
Purification of the Nucleosomes from HEK293T Cells
7:38
Nucleosome Ubiquitination Assay Using BMI1/RING1B E3 Ubiquitin Ligase Complex and In Vitro Nucleosomal H2A DUB Assay Using BAP1/DEUBAD
9:05
Results: Purification, Ubiquitination, and Deubiquitination
10:40
Conclusion
